| 000 | 01033 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250515114404.0 | ||
| 264 | 0 | _c20080710 | |
| 008 | 200807s 0 0 eng d | ||
| 022 | _a1040-8711 | ||
| 024 | 7 |
_a10.1097/BOR.0b013e3282f5e08d _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDörner, Thomas | |
| 245 | 0 | 0 |
_aNew approaches of B-cell-directed therapy: beyond rituximab. _h[electronic resource] |
| 260 |
_bCurrent opinion in rheumatology _cMay 2008 |
||
| 300 |
_a263-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aB-Lymphocytes _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aBurmester, Gerd R | |
| 773 | 0 |
_tCurrent opinion in rheumatology _gvol. 20 _gno. 3 _gp. 263-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/BOR.0b013e3282f5e08d _zAvailable from publisher's website |
| 999 |
_c17887749 _d17887749 |
||